Frequency of aac (۶ ́)-le-aph (۲ ́ ́) gene and resistance to Aminoglycoside antibiotics in Staphylococcus aureus isolates

Staphylococcus aureus is one of the most common infectious bacterial species and one of the agents of community-acquired infections (CAIs) and hospital-acquired infections (HAIs). Aminoglycosides are potent antibactericidal agents often used together with Beta Lactams or Glycopeptides, especially in treating Staphylococcal endocarditis. The present research aimed to determine the frequency of the aac (۶ ́)-le-aph (۲ ́ ́) gene that encodes Aminoglycoside modifying enzymes using PCR on clinical isolates of S. aureus. ۱۱۵ clinical isolates of S. aureus were collected at educational hospitals in Karaj during ۱۲ months. They were first identified by using standard biochemical and laboratory methods and, following CLSI principles and procedures, antibiotic sensitivity patterns of all isolates were obtained using the disc diffusion method. Moreover, using agar dilution, the minimum inhibitory concentration was determined using the antibiotic powder Gentamycin. Finally, gene frequency was measured by employing PCR. The highest levels of resistance to Aminoglycosides were observed in Kanamycin (۴۷.۸%), Gentamycin (۴۶.۹%), and Tobramycin (۴۶.۹%), and Doxycycline and Ciprofloxacin with ۵۰.۴ and ۴۹.۵ percent respectively, were the non-Aminoglycoside antibiotics to which the highest levels of resistance were exhibited. The frequency of the aac (۶ ́)-le-aph (۲ ́ ́) gene was ۳۹.۱ percent. Rapid and timely detection of resistant strains seems to be necessary in selecting suitable treatment options and in preventing the spread of resistance. Furthermore, rapid identification of genes that encode AME enzymes using PCR enjoys special advantages such as high levels of precision and speed.